The 30-s chair stand test can be a useful tool for screening sarcopenia in elderly Japanese participants.

Aged Cross-Sectional Studies Female Hand Strength Humans Japan / epidemiology Male Muscle Strength Reproducibility of Results Sarcopenia / diagnosis
Chair stand test Elderly Lower limb muscle strength Sarcopenia

Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
24 Jul 2021
Historique:
received: 12 03 2021
accepted: 13 07 2021
entrez: 25 7 2021
pubmed: 26 7 2021
medline: 28 7 2021
Statut: epublish

Résumé

Low muscle strength has been focused on as an essential characteristic of sarcopenia, and the 30-s chair stand test (CS-30) could be a particularly useful test for assessing muscle strength. While it is speculated to be a beneficial tool for the assessment of sarcopenia, this remains to be verified. In this study, we examined the reliability and optimal diagnostic score of the CS-30 for assessing sarcopenia in elderly Japanese participants. This cross-sectional study included 678 participants (443 females and 235 males) who underwent the test for sarcopenia as per the Asian Working Group for Sarcopenia (AWGS) 2019, the CS-30 test, and the isometric knee-extension muscle strength test. ROC analysis was used to estimate the optimal CS-30 scores at which sarcopenia was detected. CS-30 scores were positively associated with sarcopenia (OR: 0.88; 95% CI:0.82-0.93). The AUC of the CS-30 for sarcopenia definition were 0.84 (p < 0.001) for females and 0.80 (p < 0.001) for males. The optimal number of stands in the CS-30 that predicted sarcopenia was 15 for females (sensitivity, 76.4%; specificity, 76.8%) and 17 for males (sensitivity, 75.0%; specificity, 71.7%). The CS-30 was found to be a reliable test for sarcopenia screening in the elderly Japanese population.

Sections du résumé

BACKGROUND BACKGROUND
Low muscle strength has been focused on as an essential characteristic of sarcopenia, and the 30-s chair stand test (CS-30) could be a particularly useful test for assessing muscle strength. While it is speculated to be a beneficial tool for the assessment of sarcopenia, this remains to be verified. In this study, we examined the reliability and optimal diagnostic score of the CS-30 for assessing sarcopenia in elderly Japanese participants.
METHODS METHODS
This cross-sectional study included 678 participants (443 females and 235 males) who underwent the test for sarcopenia as per the Asian Working Group for Sarcopenia (AWGS) 2019, the CS-30 test, and the isometric knee-extension muscle strength test. ROC analysis was used to estimate the optimal CS-30 scores at which sarcopenia was detected.
RESULTS RESULTS
CS-30 scores were positively associated with sarcopenia (OR: 0.88; 95% CI:0.82-0.93). The AUC of the CS-30 for sarcopenia definition were 0.84 (p < 0.001) for females and 0.80 (p < 0.001) for males. The optimal number of stands in the CS-30 that predicted sarcopenia was 15 for females (sensitivity, 76.4%; specificity, 76.8%) and 17 for males (sensitivity, 75.0%; specificity, 71.7%).
CONCLUSIONS CONCLUSIONS
The CS-30 was found to be a reliable test for sarcopenia screening in the elderly Japanese population.

Identifiants

DOI: 10.1186/s12891-021-04524-x PMID: 34303339 PMC: PMC8310594
pubmed: 34303339
doi: 10.1186/s12891-021-04524-x
pii: 10.1186/s12891-021-04524-x
pmc: PMC8310594
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

639

Informations de copyright

© 2021. The Author(s).

Références

J Sports Sci Med. 2020 Nov 19;19(4):721-726
pubmed: 33239946
J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2
pubmed: 32033882
J Gerontol A Biol Sci Med Sci. 2014 Apr;69(4):438-46
pubmed: 24085400
Am J Epidemiol. 1998 Apr 15;147(8):755-63
pubmed: 9554417
BMC Musculoskelet Disord. 2019 Mar 14;20(1):104
pubmed: 30871499
J Am Geriatr Soc. 2009 Feb;57(2):251-9
pubmed: 19207142
J Gerontol A Biol Sci Med Sci. 2002 Aug;57(8):M539-43
pubmed: 12145369
J Phys Ther Sci. 2014 Dec;26(12):1861-3
pubmed: 25540482
J Nutr. 1997 May;127(5 Suppl):990S-991S
pubmed: 9164280
J Gerontol A Biol Sci Med Sci. 1997 Sep;52(5):M275-85
pubmed: 9310081
J Am Med Dir Assoc. 2014 Feb;15(2):95-101
pubmed: 24461239
J Nutr Health Aging. 2016 Jan;20(1):56-9
pubmed: 26728934
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
BMC Musculoskelet Disord. 2015 Oct 16;16:305
pubmed: 26474770
Res Q Exerc Sport. 1999 Jun;70(2):113-9
pubmed: 10380242
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
Geriatr Gerontol Int. 2017 Apr;17(4):659-661
pubmed: 27120799

Auteurs

Shuji Sawada (S)

COI project center, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Hayao Ozaki (H)

School of Health and Sports Science, Juntendo University, 1-1 Hirakagakuendai, Inzai, Chiba, 270-1695, Japan.
School of Sport and Health Science, Tokai Gakuen University, 21-233 Nishinohora, Ukigai, Miyoshi, Aichi, 470-0207, Japan.

Toshiharu Natsume (T)

School of Health and Sports Science, Juntendo University, 1-1 Hirakagakuendai, Inzai, Chiba, 270-1695, Japan.
Department of Human Structure & Function, Tokai University School of Medicine, 143 Shimokasuya, Iesehara, Kanagawa, 259-1193, Japan.

Pengyu Deng (P)

Graduate School of Health and Sports Science, Juntendo University, 1-1 Hirakagakuendai, Inzai, Chiba, 270-1695, Japan.

Toshinori Yoshihara (T)

Graduate School of Health and Sports Science, Juntendo University, 1-1 Hirakagakuendai, Inzai, Chiba, 270-1695, Japan.

Takashi Nakagata (T)

School of Health and Sports Science, Juntendo University, 1-1 Hirakagakuendai, Inzai, Chiba, 270-1695, Japan.
Department of Physical Activity Research, National Institutes of Biomedical Innovation, Health and Nutrition, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8636, Japan.

Takuya Osawa (T)

School of Health and Sports Science, Juntendo University, 1-1 Hirakagakuendai, Inzai, Chiba, 270-1695, Japan.
Faculty of Sports and Health Sciences, Japan Women's College of Physical Education, 8-19-1, Kitakarasuyama, Setagaya-ku, Chiba, Tokyo, 157-8565, Japan.

Yoshihiko Ishihara (Y)

School of Health and Sports Science, Juntendo University, 1-1 Hirakagakuendai, Inzai, Chiba, 270-1695, Japan.
School of Science and Technology for Future Life, Tokyo Denki University, 5 Senju Asahi-cho, Adachi-ku, Tokyo, 120-8551, Japan.

Tomoharu Kitada (T)

School of Health and Sports Science, Juntendo University, 1-1 Hirakagakuendai, Inzai, Chiba, 270-1695, Japan.
Faculty of Business Administration, Seijoh University, 2-172 Fukinodai, Tokai City, Aichi, 476-8588, Japan.

Ken Kimura (K)

School of Engineering, Tokyo Denki University, 5 Senju Asahi-cho, Adachi-ku, Tokyo, 120-8551, Japan.

Nobuhiro Sato (N)

Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Shuichi Machida (S)

COI project center, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. machidas@juntendo.ac.jp.
School of Health and Sports Science, Juntendo University, 1-1 Hirakagakuendai, Inzai, Chiba, 270-1695, Japan. machidas@juntendo.ac.jp.
Graduate School of Health and Sports Science, Juntendo University, 1-1 Hirakagakuendai, Inzai, Chiba, 270-1695, Japan. machidas@juntendo.ac.jp.
Institute of Health and Sports Science & Medicine, Juntendo University, 1-1 Hirakagakuendai, Inzai, Chiba, 113-8421, Japan. machidas@juntendo.ac.jp.

Hisashi Naito (H)

School of Health and Sports Science, Juntendo University, 1-1 Hirakagakuendai, Inzai, Chiba, 270-1695, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › The 30-s chair stand test can be a useful tool...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › The 30-s chair stand test can be a useful tool...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système locomoteur › Force musculaire › Force de la main › The 30-s chair stand test can be a useful tool...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The 30-s chair stand test can be a useful tool...
questionsmedicales.fr › Régions géographiques › Iles › Japon › The 30-s chair stand test can be a useful tool...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système locomoteur › Force musculaire › The 30-s chair stand test can be a useful tool...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Reproductibilité des résultats › The 30-s chair stand test can be a useful tool...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations neurologiques › Manifestations neuromusculaires › Amyotrophie › Sarcopénie › The 30-s chair stand test can be a useful tool...